Valuation: Hansoh Pharmaceutical Group Company Limited

Capitalization 23TCr 26TCr 3.33TCr 2.86TCr 2.66TCr 2.48TCr 4.63TCr 3,01000Cr 4.99TCr 31TCr 12TCr 1,44000Cr 13TCr 12TCr 5,27600Cr P/E ratio 2025 *
44.6x
P/E ratio 2026 * 42.2x
Enterprise value 21TCr 23TCr 2.96TCr 2.54TCr 2.36TCr 2.2TCr 4.1TCr 2,67000Cr 4.42TCr 27TCr 11TCr 1,27700Cr 11TCr 11TCr 4,68000Cr EV / Sales 2025 *
14x
EV / Sales 2026 * 12.7x
Free-Float
18.75%
Yield 2025 *
0.81%
Yield 2026 * 0.84%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.47%
1 week+7.74%
Current month+19.57%
1 month+8.56%
3 months+24.47%
6 months+32.33%
Current year+19.57%
More quotes
1 week 39.94
Extreme 39.94
44.22
1 month 35.54
Extreme 35.54
44.22
Current year 35.7
Extreme 35.7
44.22
1 year 16.5
Extreme 16.5
44.22
3 years 9.41
Extreme 9.41
44.22
5 years 9.41
Extreme 9.41
46.7
10 years 9.41
Extreme 9.41
46.7
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 02/12/2015
Corporate Secretary 37 26/12/2025
Corporate Secretary 58 01/08/2018
Director TitleAgeSince
Chairman 65 02/12/2015
Director/Board Member 49 11/03/2016
Director/Board Member 39 02/12/2015
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.51%+7.74%+159.25%+153.17% 3.26TCr
-0.36%+0.87%+34.59%+196.80% 96TCr
+2.29%+6.72%+51.28%+26.02% 51TCr
+0.52%-0.91%+25.55%+44.46% 39TCr
+0.94%+4.30%+29.90%+17.96% 36TCr
+2.41%+2.19%+32.56%+23.08% 29TCr
+2.13%+4.07%+27.83%+37.35% 27TCr
+2.54%+1.97%+9.93%-1.10% 27TCr
-1.32%+3.90%-38.31%-19.23% 27TCr
+1.44%-0.36%+21.76%+21.07% 17TCr
Average +0.98%+1.61%+35.43%+49.96% 35.38TCr
Weighted average by Cap. +0.74%+0.40%+28.03%+69.89%
See all sector performances

Financials

2025 *2026 *
Net sales 1.47TCr 1.64TCr 210.68Cr 180.79Cr 168.33Cr 156.64Cr 292.31Cr 19TCr 315.12Cr 1.94TCr 761.34Cr 9.1TCr 790.14Cr 773.85Cr 33TCr 1.6TCr 1.78TCr 228.91Cr 196.43Cr 182.89Cr 170.2Cr 317.6Cr 21TCr 342.38Cr 2.1TCr 827.21Cr 9.89TCr 858.51Cr 840.81Cr 36TCr
Net income 505.23Cr 564.96Cr 72Cr 62Cr 58Cr 54Cr 100.53Cr 6.54TCr 108.37Cr 665.56Cr 261.83Cr 3.13TCr 271.74Cr 266.14Cr 11TCr 543.33Cr 607.56Cr 78Cr 67Cr 62Cr 58Cr 108.11Cr 7.03TCr 116.54Cr 715.74Cr 281.58Cr 3.36TCr 292.23Cr 286.2Cr 12TCr
Net Debt -2.63TCr -2.94TCr -376.56Cr -323.13Cr -300.86Cr -279.97Cr -522.46Cr -34TCr -563.23Cr -3.46TCr -1.36TCr -16TCr -1.41TCr -1.38TCr -60TCr -3.03TCr -3.38TCr -433.92Cr -372.35Cr -346.69Cr -322.62Cr -602.04Cr -39TCr -649.02Cr -3.99TCr -1.57TCr -19TCr -1.63TCr -1.59TCr -69TCr
More financial data * Estimated data
Logo Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.
Employees
9,313
More about the company
Date Price Change Volume
15/26/15 43.16 $ +0.51% 11,21,003
14/26/14 42.94 $ +2.14% 1,01,59,880
13/26/13 42.04 $ +3.44% 59,89,850
12/26/12 40.64 $ -2.31% 73,17,694
09/26/09 41.60 $ +2.11% 63,94,341

Delayed Quote Hong Kong S.E., January 15, 2026 at 07:12 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
38.40CNY
Average target price
40.67CNY
Spread / Average Target
+5.91%
Consensus

Quarterly revenue - Rate of surprise